Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III StudyHans von der Maase, PierFranco Conte, J.T. Roberts et al.|Journal of Clinical Oncology|2000Cited by 2.3k
Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische OnkologieSalah‐Eddin Al‐Batran, Elke Jäger, J. T. Hartmann et al.|Journal of Clinical Oncology|2008Cited by 784
Classification of current anticancer immunotherapiesLorenzo Galluzzi, Enrico Lugli, Guido Kroemer et al.|Oncotarget|2014Cited by 469
NY‐ESO‐1: Review of an Immunogenic Tumor AntigenSacha Gnjatic, Lloyd J. Old, Hiroyoshi Nishikawa et al.|Advances in cancer research|2006Cited by 455
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancersElke Jäger, Alexander Knuth, Sacha Gnjatic et al.|Proceedings of the National Academy of Sciences|2000Cited by 426